← Leaderboards
Huiping Rose Zhou
Va Veterans Administration Hospital
$7,173,248
Attributed
$10,982,917
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,982,917 · 9
VA$0 · 7
By mechanism
R01$9,542,595 · 6
R21$810,740 · 2
R56$629,582 · 1
I01$0 · 4
IK6$0 · 1
IS1$0 · 2
Top collaborators
- Phillip B Hylemon17 shared
- Dennis Edward Ohman2 shared
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayMolecularBaseReportingBile AcidsLinkMediatingLiver DiseasesHepaticProteinsHepatocyteSignal PathwayLipidsLiver InjuryInflammationSignal TransductionHomeostasisPathogenesisLipid MetabolismLiverNovel TherapeuticsMouse ModelFunctional DisorderGenes
Grant awards (49)
Circular RNAs in Cholestatic Liver Diseases$561,785
R01 · FY2025 · DK · contact PI
Sphingolipids in alcoholic liver disease$523,062
R01 · FY2025 · AA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Bile Acids and Sphingosine 1-Phosphate in Non-Alcoholic Steatohepatitis (NASH)$0
I01 · FY2025 · VA · contact PI
Pathogenic Mechanism for Lung Infection in Mucoid Pseudomonas$0
I01 · FY2025 · VA · contact PI
Circular RNAs in Cholestatic Liver Diseases$561,785
R01 · FY2024 · DK · contact PI
Sphingolipids in alcoholic liver disease$523,062
R01 · FY2024 · AA · contact PI
Bile Acids and Sphingosine 1-Phosphate in Non-Alcoholic Steatohepatitis (NASH)$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Pathogenic Mechanism for Lung Infection in Mucoid Pseudomonas$0
I01 · FY2024 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$629,582
R56 · FY2023 · DK · contact PI
Sphingolipids in alcoholic liver disease$523,062
R01 · FY2023 · AA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Bile Acids and Sphingosine 1-Phosphate in Non-Alcoholic Steatohepatitis (NASH)$0
I01 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2021 · DK · contact PI
The ShEEP request for NanoString GeoMx Digital Spatial Profiling and nCounter MAX Complete System$0
IS1 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease$0
I01 · FY2021 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2020 · DK · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$399,609
R01 · FY2020 · DK · contact PI
Sphingosine-1 phosphate signaling in alcoholic liver disease$184,359
R21 · FY2020 · AA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease$0
I01 · FY2020 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2019 · DK · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$393,548
R01 · FY2019 · DK · contact PI
Sphingosine-1 phosphate signaling in alcoholic liver disease$223,112
R21 · FY2019 · AA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease$0
I01 · FY2019 · VA · contact PI
The ShEEP request for Waters Xevo TQ-XS Liquid Chromatography Mass Spectrometer System$0
IS1 · FY2019 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$535,606
R01 · FY2018 · DK · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$390,905
R01 · FY2018 · DK · contact PI
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease$0
I01 · FY2018 · VA · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$390,481
R01 · FY2017 · DK · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$411,742
R01 · FY2016 · DK · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2015 · DK
Impact of Alcohol on HIV Protease Inhibitor-induced ER Stress and Lipotoxicity$0
I01 · FY2015 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2014 · DK
Impact of Alcohol on HIV Protease Inhibitor-induced ER Stress and Lipotoxicity$0
I01 · FY2014 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$313,783
R01 · FY2013 · DK
Impact of Alcohol on HIV Protease Inhibitor-induced ER Stress and Lipotoxicity$0
I01 · FY2013 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2012 · DK
Impact of Alcohol on HIV Protease Inhibitor-induced ER Stress and Lipotoxicity$0
I01 · FY2012 · VA · contact PI
Prevent HIV protease inhibitor-induced atherosclerosis by Berberine$355,517
R01 · FY2010 · AT · contact PI
Prevent HIV protease inhibitor-induced atherosclerosis by Berberine$359,336
R01 · FY2009 · AT · contact PI
Prevent HIV protease inhibitor-induced atherosclerosis by Berberine$359,556
R01 · FY2008 · AT · contact PI
Prevent HIV protease inhibitor-induced atherosclerosis by Berberine$354,860
R01 · FY2007 · AT · contact PI
HIV Protease Inhibitors, the Unfolded Protein Response and Atherosclerosis$217,019
R21 · FY2007 · AI · contact PI
HIV Protease Inhibitors, the Unfolded Protein Response and Atherosclerosis$186,250
R21 · FY2006 · AI · contact PI